Novel Thrombopoietic Agents: A Review of Their Use in Idiopathic Thrombocytopenic Purpura

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.7, 2008-01, pp. : 901-912

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eltrombopag: a guide to its use in chronic immune (idiopathic) thrombocytopenic purpura

Drugs & Therapy Perspectives, Vol. 27, Iss. 2, 2011-02 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Romiplostim: a guide to its use in immune (idiopathic) thrombocytopenic purpura

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 6, 2009-06 ,pp. : 6-9

Adis International

Access to resources Recommend Favorite

Biologic Aspects of Thrombopoietin and the Development of Novel Thrombopoietic Agents for Clinical Use

Current Drug Discovery Technologies, Vol. 4, Iss. 3, 2007-10 ,pp. : 162-173

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Immune Thrombocytopenic Purpura in Children: Potential Role of Novel Agents

By >

Pediatric Drugs, Vol. 13, Iss. 4, 2011-08 ,pp. : 213-223

Adis International

Access to resources Recommend Favorite

Emerging drugs for idiopathic thrombocytopenic purpura in adults

By Li Xiaofang Hou Ming

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 237-254

Informa Healthcare

Access to resources Recommend Favorite